Stockscreener 앱 받기
0.6827
4.92%
-0.0353
시장 영업 전:
.62
-0.0627
-9.18%
전일 마감가:
$0.718
열려 있는:
$0.6843
하루 거래량:
126.97K
Relative Volume:
0.47
시가총액:
$27.66M
수익:
$3.99M
순이익/손실:
$-3.55M
주가수익비율:
-1.2392
EPS:
-0.5509
순현금흐름:
$94,500
1주 성능:
+8.88%
1개월 성능:
-4.65%
6개월 성능:
-47.08%
1년 성능:
-62.90%
1일 변동 폭
$0.6827
$0.7988
1주일 범위
$0.60
$0.7988
52주 변동 폭
$0.3818
$2.0299
China Pharma Holdings Inc. Stock (CPHI) Company Profile
명칭
China Pharma Holdings Inc.
전화
86 898 6681 1730
주소
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.6827 | 26.75M | 3.99M | -3.55M | 94,500 | -0.5509 |
TAK
Takeda Pharmaceutical Co Adr
|
16.89 | 50.65B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.72 | 41.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.29 | 39.45B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
75.42 | 30.13B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
547.25 | 23.00B | 3.17B | 1.29B | 1.01B | 27.09 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2010-01-08 | 개시 | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. 주식(CPHI)의 최신 뉴스
World Pharmaceutical Grade Amino Acid GlobalMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Price to earnings forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
Price to sales forward of China Pharma Holdings, Inc. – AMEX:CPHI - TradingView
China Pharma Holdings Inc (CPHI) Institutional Confidence - TradingKey
Liposomal Delivery System Market Growth Outlook to 2035: Semiconductor and Electronics Applications Accelerate DemandNews and Statistics - IndexBox
China Pharma Holdings Inc (CPHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AYTU Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Nuvectis Pharma Expands Pipeline with Exclusive Ex-China Rights to Haisco’s NXP100 and NXP200 Clinical-Stage Candidates - Quiver Quantitative
Ascentage Pharma Group International (AAPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Pharma Holdings Inc (CPHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China Pharma (CPHI) Stock Forecast & Analyst Ratings - Moomoo
China Pharma Holdings Inc (CPHI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
China Pharma Holdings Inc (CPHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China Pharma Holdings Inc (CPHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China Pharma Holdings Inc (CPHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China Pharma Holdings Inc (CPHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China Pharma Holdings Inc (CPHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
World Gel Matrix Transdermal SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Chewy Reports Strong FQ1 2026 Results; Analysts Highlight Mid-Cap Growth PotentialProduct Revenue Analysis - newsline.com
AMC Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts Investor SentimentGuidance Accuracy Score - newsline.com
Japanese Pharma Giants Look to China for Drug Discovery and Growth OpportunitiesEarnings Surprise Stocks - newsline.com
Shanghai Fosun Pharmaceutical Stock (CNE100000536): shares in focus amid quiet news flow - AD HOC NEWS
CPHI Q3 2011 Earnings: Significant EPS Miss Amid Challenging QuarterRevenue Report - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Amid Challenging QuarterEarnings Trend Analysis - newsline.com
OGE Energy Slips 2.9%: Defensive Utility Faces Technical HeadwindsBreakout Confirmation - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates Significantly, Stock DeclinesMargin Improvement Report - newsline.com
Arrowhead Pharmaceuticals Q1 2026 Earnings: EPS Surprise on Lower Expenses Offsets Revenue VoidDividend Increase Stocks - newsline.com
Marvell Technology and Flex Set to Join S&P 500, Replacing Pool and Campbell’sPost-Announcement Reaction - newsline.com
CPHI Q3 2011 Earnings: EPS Misses Estimates, Stock Declines 12.9%Earnings Volatility Report - newsline.com
May Jobs Report Expected to Show Slower Hiring: Reality Check for Strong StartGross Profit Margin - newsline.com
The Pharma Choke Point - Council on Foreign Relations
China Pharma Holdings (CPHI) Holds Steady at $0.79 as Key Support and Resistance Levels Remain in FocusProfitability Factor - The Legal Advocate
China NT Pharma Group Announces Proposed Disposal of NT Pharma (Overseas) Holding Co., Ltd Equity Interests to Alleviate Liquidity Strain 12 - Minichart
Walmart Inc. Q1 2026 Financial Report: Earnings, Assets, Shareholder Equity, and SEC Filings Analysis - Minichart
KOP Q1 2026 Earnings: EPS Surprises by Nearly 30% Amid Revenue Silence, Stock SlipsEstimate Uncertainty - The Legal Advocate
symbol__ Stock Quote Price and Forecast - CNN
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Udemy Inc. (UDMY) Stabilizes Near Support as Market Awaits CatalystChandelier Stop - The Legal Advocate
China Pharma Company Profile & Introduction - Moomoo
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says - Yahoo Finance
Plasma Fractionation Market Size, Share, Growth, Analysis, 2034 - Straits Research
China Pharma Holdings (CPHI) Q3 2011 Earnings: EPS Miss Weighs on SentimentEPS Guidance Update - newsline.com
CPHI Q3 2011 Earnings: EPS Falls Short of Consensus Amid Operational HeadwindsPerformance Review - newsline.com
Rafael Holdings (RFL) Sees Modest Uptick, Testing Key Resistance at $1.41MA Cross Alert - The Legal Advocate
CPHI Stock Chart | CHINA PHARMA HOLDINGS INC (NYSEARCA:CPHI) - ChartMill
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
Trump's China Visit: US CEOs Musk, Cook and Nvidia’s Huang Join Trade TalksEarnings Forecast Report - newsline.com
China Pharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
South Korea’s Reversal on AI Tax Proposal Seen as Positive Signal for Micron (MU) StockShare Dilution Risk - newsline.com
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity - digitalmore.co
China Pharma Holdings Inc. (CPHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
0.14%
자본화:
|
볼륨(24시간):